Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility

Molecular Biology Reports

Volumn 39, Issue 9, 2012, Pages 9023-9030

  Lin, Hsiu Ling ^a,b   Ueng, Kwo Chang ^a,b   Hsieh, Yih Shou ^a,b   Chiang, Whei Ling ^a   Yang, Shun Fa ^a   Chu, Shu Chen ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

CCR 2; Coronary artery disease; MCP 1; Single nucleotide polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ALLELE; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART ATRIUM FIBRILLATION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TAIWANESE;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL2; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; RISK FACTORS;

EID: 84865130728     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1773-y     Document Type: Article

References (44)

1. WHO (2004) WHO publishes definitive atlas on global heart disease and stroke epidemic. Indian J Med Sci 58:405-406
2. Libby P (2001) What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol 88:3J-6J (Pubitemid 32938245)
3. Egorova MO (2002) Increased serum level of the acute inflammation phase parameter CRP and the high level of low density lipoprotein cholesterol-factors of increased risk of development of atherosclerosis and its complications. Klin Lab Diagn 6:3-6
4. Owen DR, Lindsay AC, Choudhury RP, Fayad ZA (2011) Imaging of atherosclerosis. Annu Rev Med 62:25-40
5. Faggiotto A, Ross R (1984) Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4:341-356 (Pubitemid 14092677)
6. Ross R, Faggiotto A, Bowen-Pope D, Raines E (1984) The role of endothelial injury and platelet and macrophage interactions in atherosclerosis. Circulation 70:77-82
7. Joris I, Zand T, Majno G (1982) Hydrodynamic injury of the endothelium in acute aortic stenosis. Am J Pathol 106:394-408 (Pubitemid 12192662)
8. Harrington JR (2000) The role of MCP-1 in atherosclerosis. Stem Cells 18:65-66 (Pubitemid 30064895)
9. Mach F (2001) The role of chemokines in atherosclerosis. Curr Atheroscler Rep 3:243-251
10. Nelken NA, Coughlin SR, Gordon D, Wilcox JN (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121-1127
11. Shibasaki I, Nishikimi T, Mochizuki Y, Yamada Y, Yoshitatsu M, Inoue Y (2010) Greater expression of inflammatory cytokines, adrenomedullin, and natriuretic peptide receptor-C in epicardial adipose tissue in coronary artery disease. Regul Pept 165:210-217
12. Hojo Y, Ikeda U, Takahashi M, Shimada K (2002) Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 161:403-408 (Pubitemid 34219194)
13. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M et al (2005) Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 69:1484-1489 (Pubitemid 41743963)
14. Eriksson EE (2004) Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol 15:553-558 (Pubitemid 39336583)
15. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126 (Pubitemid 29054847)
16. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ et al (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256 (Pubitemid 21914722)
17. Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W et al (2002) Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol 22:914-920 (Pubitemid 34655217)
18. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344-348 (Pubitemid 29281234)
19. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897 (Pubitemid 28410911)
20. Simeoni E, Winkelmann BR, Hoffmann MM, Fleury S, Ruiz J, Kappenberger L et al (2004) Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 25:1438-1446 (Pubitemid 39078251)
21. Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B et al (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158:233-239 (Pubitemid 32735489)
22. Jemaa R, Ben Ali S, Kallel A, Omar S, Feki M, Elasmi M et al (2009) Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients. Clin Biochem 42:34-37
23. Zhang X, Han Y, Kang J, Yan C (2009) A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clin Chim Acta 403:241-243
24. Cermakova Z, Petrkova J, Arakelyan A, Drabek J, Mrazek F, Lukl J et al (2005) The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunogenet 32:315-318 (Pubitemid 41392376)
25. Bjarnadottir K, Eiriksdottir G, Aspelund T, Gudnason V (2006) Examination of genetic effects of polymorphisms in the MCP-1 and CCR2 genes on MI in the Icelandic population. Atherosclerosis 188:341-346 (Pubitemid 44301143)
26. Cam SF, Sekuri C, Sagcan A, Ercan E, Tengiz I, Alioglu E et al (2008) Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest 68:801-805
27. Bucova M, Lietava J, Mrazek F, Petrkova J, Bernadic M, Buckingham T et al (2008) Association of chronic stable angina pectoris with MCP-1-2518 A/G single nucleotide polymorphism in the Slovak population. Clin Chim Acta 392:71-72
28. Iwai N, Kajimoto K, Kokubo Y, Okayama A, Miyazaki S, Nonogi H et al (2006) Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J 70:805-809 (Pubitemid 43979113)
29. El Mahgoub IR, Afify RA, Aal AA, Beda DG (2011) Association between the monocyte chemoattractant protein-1 -2518G/A gene polymorphism and acute myocardial infarction patients among Egyptian population. Blood Coagul Fibrinolysis 22:7-13
30. van Wijk DF, van Leuven SI, Sandhu MS, Tanck MW, Hutten BA, Wareham NJ et al (2010) Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30:1460-1466
31. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y et al (1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4:350-353 (Pubitemid 28144097)
32. Petrkova J, Cermakova Z, Drabek J, Lukl J, Petrek M (2003) CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction. Immunol Lett 88:53-55 (Pubitemid 36835850)
33. Chen MK, Yeh KT, Chiou HL, Lin CW, Chung TT, Yang SF (2011) CCR2-64I gene polymorphism increase susceptibility to oral cancer. Oral Oncol 47:577-582
34. Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E (2002) An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI risk score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 23:223-229 (Pubitemid 36358244)
35. Bursill CA, Channon KM, Greaves DR (2004) The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr Opin Lipidol 15:145-149 (Pubitemid 38453402)
36. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF Jr et al (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham heart study. Circulation 112:1113-1120 (Pubitemid 41216117)
37. Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I et al (2003) Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 26:677-683 (Pubitemid 37258653)
38. González P, Alvarez R, Batalla A, Reguero JR, Alvarez V, Astudillo A et al (2001) Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun 2:191-195 (Pubitemid 33676982)
39. Ghilardi G, Biondi ML, Turri O, Pateri F, d'Eril GM, Scorza R (2008) Genetic control of chemokines in severe human internal carotid artery stenosis. Cytokine 41:24-28 (Pubitemid 350309714)
40. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA et al (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886-2891 (Pubitemid 33139098)
41. Ellinor PT, Low A, Patton KK, Shea MA, MacRae CA (2006) C-Reactive protein in lone atrial fibrillation. Am J Cardiol 97:1346-1350
42. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA et al (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108:3006-3010 (Pubitemid 37553570)
43. Pan M, Zhu JH, Jiang WP, Liu ZH, Li HM, Yu XH et al (2006) Inflammation: a possible pathogenic link to atrial fibrillation. Med Hypotheses 67:1305-1307 (Pubitemid 44442636)
44. Issac TT, Dokainish H, Lakkis NK (2007) Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 50:2021-2028 (Pubitemid 350087568)